Victory Capital Management Inc. Sells 63,091 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Victory Capital Management Inc. reduced its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 19.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 267,597 shares of the company's stock after selling 63,091 shares during the period. Victory Capital Management Inc. owned 0.31% of HealthEquity worth $21,903,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in HQY. Janney Montgomery Scott LLC increased its stake in HealthEquity by 27.4% in the 1st quarter. Janney Montgomery Scott LLC now owns 3,970 shares of the company's stock valued at $324,000 after buying an additional 855 shares during the last quarter. US Bancorp DE raised its stake in shares of HealthEquity by 4.8% during the 1st quarter. US Bancorp DE now owns 11,489 shares of the company's stock valued at $938,000 after purchasing an additional 521 shares during the period. State Board of Administration of Florida Retirement System grew its position in shares of HealthEquity by 11.1% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 26,663 shares of the company's stock valued at $2,177,000 after purchasing an additional 2,660 shares in the last quarter. Vanguard Group Inc. lifted its position in HealthEquity by 1.7% during the first quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company's stock valued at $715,783,000 after purchasing an additional 149,133 shares during the last quarter. Finally, Ontario Teachers Pension Plan Board purchased a new position in shares of HealthEquity during the 1st quarter valued at about $363,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 8,250 shares of the company's stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the sale, the director now directly owns 54,719 shares of the company's stock, valued at $4,540,582.62. This represents a 13.10 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Frank Corvino sold 1,247 shares of the firm's stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the transaction, the director now directly owns 4,823 shares of the company's stock, valued at approximately $387,093.98. This trade represents a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 10,536 shares of company stock worth $884,517 in the last 90 days. 2.20% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Bank of America raised their price target on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a report on Wednesday, November 13th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. JMP Securities reiterated a "market outperform" rating and set a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. BTIG Research raised their target price on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Finally, Barrington Research reiterated an "outperform" rating and issued a $105.00 price objective on shares of HealthEquity in a report on Friday, September 20th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $107.23.

HealthEquity Price Performance

Shares of NASDAQ:HQY traded up $0.27 during trading on Tuesday, hitting $102.67. 604,755 shares of the company's stock were exchanged, compared to its average volume of 624,765. The business's 50-day simple moving average is $85.54 and its 200 day simple moving average is $81.25. The company has a market cap of $8.97 billion, a price-to-earnings ratio of 85.33, a PEG ratio of 1.55 and a beta of 0.52. HealthEquity, Inc. has a 52-week low of $62.10 and a 52-week high of $103.12. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million for the quarter, compared to analysts' expectations of $284.48 million. As a group, equities analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.